Cognoptix Announces Formation of a New Board of Directors
News provided by
Share this article
Share this article
MARLBOROUGH, Mass., Dec. 30, 2020 /PRNewswire/ Cognoptix is a breakthrough diagnostics company developing an innovative office-based device-drug system for the early detection of Alzheimer s disease (AD). As another milestone of the Series R restart, recapitalization, and revitalization, the company named a new Board of Directors (BOD) formed under the leadership of Dr. Susanne Wilke, Ph.D., Cognoptix new President and CEO.
In addition to Dr. Wilke, the five-member board includes Dr. Lee E. Goldstein, Cognoptix co-founder and co-chair of the company s Scientific Advisory Board (SAB); R. Gregg Stone and John Conley, both are members of the Launchpad Venture Group which led the Cognoptix Series R fundraising and is a nationally recognized leader among angel networks; and H. Lawrence Remmel, Esq., Partner and Chair of the Banking and Finance Group at Pryor Cashman.
Skip to main content
Currently Reading We re very excited to bring the students back : Westport middle school mold free and set to reopen
DJ Simmons
FacebookTwitterEmail
A rental industrial strength dehumidification system has been set up at Coleytown Middle School to address the school s ongoing issues with mold growth. Photo taken on Sept. 14, 2018.Sophie Vaughan / Hearst Connecticut Media
WESTPORT Coleytown Middle School is set to reopen in January ending a two year saga and a $32 million project.
On Monday, the Board of Education reviewed a final presentation on the remediation project at CMS, which closed in 2018 due to mold problems. Newfield Construction was hired as construction manager, while EnviroMed was hired as the industrial hygienists.